China Medical & HealthCare Group Limited provided consolidated earnings guidance for the eleven months ended 30 November 2022. For the period, the company group is expected to record a loss attributable to shareholders of the Company ("Net Loss") for the eleven months ended 30 November 2022 which represents (a) an approximately 26% decrease as compared with the Net Loss for the corresponding period in 2021; (b) an approximately 30% to 50% decrease when compared with the Net Loss for the year ended 31 December 2021; but (c) an approximately 20% to 40% increase when compared with the Net Loss for the year ended 31 December 2021 excluding the one-off non-recurring item of impairment loss under expected credit loss model recognized on loan receivable.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7 HKD | 0.00% | +2.94% | -12.50% |
1st Jan change | Capi. | |
---|---|---|
-12.50% | 97.31M | |
-20.29% | 16.5B | |
+4.50% | 12.81B | |
+3.32% | 11.7B | |
+2.54% | 10.09B | |
+30.53% | 8.75B | |
-2.64% | 7.77B | |
+6.30% | 6.67B | |
+8.41% | 6.42B | |
+46.06% | 4.54B |
- Stock Market
- Equities
- 383 Stock
- News Tian An Medicare Limited
- China Medical & Healthcare Group Limited Provides Consolidated Earnings Guidance for the Eleven Months Ended 30 November 2022